Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 26;19(4):182.
doi: 10.3390/md19040182.

Omega-3 Fatty Acids Upregulate SIRT1/3, Activate PGC-1α via Deacetylation, and Induce Nrf1 Production in 5/6 Nephrectomy Rat Model

Sung Hyun Son  1 , Su Mi Lee  2 , Mi Hwa Lee  3 , Young Ki Son  2 , Seong Eun Kim  2 , Won Suk An  2
Affiliations

Omega-3 Fatty Acids Upregulate SIRT1/3, Activate PGC-1α via Deacetylation, and Induce Nrf1 Production in 5/6 Nephrectomy Rat Model

Sung Hyun Son et al. Mar Drugs. .

Abstract

Mitochondrial dysfunction contributes to the pathogenesis of kidney injury related with cardiovascular disease. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) protects renal tubular cells by upregulating nuclear factor erythroid 2-related factor 2 (Nrf2). AMP-activated protein kinase (pAMPK)-mediated phosphorylation and sirtuin 1/3 (SIRT1/3)-mediated deacetylation are required for PGC-1α activation. In the present study, we aimed to investigate whether omega-3 fatty acids (FAs) regulate the expression of mediators of mitochondrial biogenesis in 5/6 nephrectomy (Nx) rats. Male Sprague-Dawley rats were assigned to the following groups: sham control, Nx, and Nx treated with omega-3 FA. The expression of PGC-1α, phosphorylated PGC-1α (pPGC-1α), acetylated PGC-1α, and factors related to mitochondrial biogenesis was examined through Western blot analysis. Compared to the control group, the expression of PGC-1α, pAMPK, SIRT1/3, Nrf1, mTOR, and Nrf2 was significantly downregulated, and that of Keap 1, acetylated PGC-1α, and FoxO1/3, was significantly upregulated in the Nx group. These changes in protein expression were rescued in the omega-3 FA group. However, the expression of pPGC-1α was similar among the three groups. Omega-3 FAs may involve mitochondrial biogenesis by upregulating Nrf1 and Nrf2. This protective mechanism might be attributed to the increased expression and deacetylation of PGC-1α, which was triggered by SIRT1/3.

Keywords: nuclear factor erythroid 2-related factor 2; nuclear respiratory factor 1; omega-3 fatty acid; peroxisome proliferator-activated receptor gamma coactivator-1 alpha; sirtuin 1; sirtuin 3.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Expressions of (A) Nrf1 and (B) Nrf2 (n = 6/group). Decreased Nrf 1 and Nrf2 expressions of 5/6 nephrectomy group were improved by omega-3 FA supplementation. * p value < 0.05 (mean values are significantly different from control). a p value < 0.05 (mean values are significantly different from the Nx group).
Figure 2
Figure 2
Changes in the (A) expression of PGC-1α and (B) activity of PGC-1α (n = 6/group). Decreased PGC-1α expressions of 5/6 nephrectomy group were improved by omega-3 FA supplementation. The deacetylation status of PGC-1α was improved by omega-3 FA supplementation. p-PGC-1α, phosphorylated PGC-1α. PGC-1α-Ac, acetylated PGC-1α. * p value < 0.05 (mean values are significantly different from control). a p value < 0.05 (mean values are significantly different from the Nx group).
Figure 3
Figure 3
Changes in the expression of factors related to the function of PGC-1α (n = 6/group): (A) phosphorylation of AMPK (the ratio of pAMPK to AMPK), (B) expression of SIRT1, and (C) SIRT3. Decreased SIRT3 expressions of 5/6 nephrectomy group were improved by omega-3 FA supplementation. * p value < 0.05 (mean values are significantly different from control). a p value < 0.05 (mean values are significantly different from the Nx group).
Figure 4
Figure 4
Changes in the expression of mTOR and Keap1 (A–C, n = 6/group). Changes in the expression of FoxO1 and FoxO3 (D–F, n = 6/group). Decreased mTOR and increased Keap1, FoxO1, and FoxO3 expressions of 5/6 nephrectomy group were improved by omega-3 FA supplementation. * p value < 0.05 (mean values are significantly different from control). a p value < 0.05 (mean values are significantly different from the Nx group).
Figure 5
Figure 5
Effect of omega-3 FA on mitochondrial biogenesis in CKD. Bold black arrows indicate the expression of mediators related to mitochondrial biogenesis in a CKD rat model. Red arrows indicate the expression of mediators after omega-3 FA administration. Up/down arrows indicate an increase and decrease in the expression of mediators.
See this image and copyright information in PMC

References

    1. Bhatia D., Capili A., Choi M.E. Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches. Kidney Res. Clin. Pract. 2020;39:244–258. doi: 10.23876/j.krcp.20.082. - DOI - PMC - PubMed
    1. Bhargava P., Schnellmann R.G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 2017;13:629–646. doi: 10.1038/nrneph.2017.107. - DOI - PMC - PubMed
    1. Lee M.S., Shin Y., Moon S., Kim S., Kim Y. Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Mitochondrial DNA Replication and PGC-1alpha Gene Expression in C2C12 Muscle Cells. Prev. Nutr. Food Sci. 2016;21:317–322. doi: 10.3746/pnf.2016.21.4.317. - DOI - PMC - PubMed
    1. Park J.S., Davis R.L., Sue C.M. Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives. Curr. Neurol. Neurosci. Rep. 2018;18:21. doi: 10.1007/s11910-018-0829-3. - DOI - PMC - PubMed
    1. Yuan Y., Huang S., Wang W., Wang Y., Zhang P., Zhu C., Ding G., Liu B., Yang T., Zhang A. Activation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Kidney Int. 2012;82:771–789. doi: 10.1038/ki.2012.188. - DOI - PubMed

MeSH terms